Director, Bone Marrow Transplant Service; Clinical Leader, Hematologic Oncology; Professor, Medical Oncology
Hematology
Dr. Henry Fung, MD
|
|
Give Review
Henry Fung practices Hematology. He received 5 awards: "American Top Doctor (Cancer)", "America's Top Doctor (Hem)", "FRCPE", "FACP" and "CMS Meaningful Use Stage 1 Certification". Henry Fung, MD is a published doctor as well. He has 42 publications published. The latest was: Bone marrow transplantation for adults with acute leukaemia and 11q23 chromosomal abnormalities. Doctor Henry Fung, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.
- Anger, provider responses, and pain: Prospective analysis of stem Cell transplant patients.
- Posttraumatic stress symptoms predict impaired neutrophil recovery in stem Cell transplant recipients.
- A phase 1 dose-escalation study of XmAb 2513 in patients with relapsed or refractory Hodgkin Lymphoma.
- Gastrointestinal Side Effects and Adequacy of Enteral Intake in Hematopoietic Stem Cell Transplant Patients.
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
- Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem Cell transplantation.
- Loss of CD26 protease activity in recipient mice during hematopoietic stem Cell transplantation results in improved transplant efficiency.
- Clinical and safety profile of high-dose interleukin-2 treatment in elderly patients with metastatic melanoma and renal Cell carcinoma.
- CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood Cells to CXCL12/SDF-1.
- A simplified technique for delivering total body irradiation (TBI) with improved dose homogeneity.
- Induction chemotherapy before autologous stem Cell transplantation for symptomatic plasma Cell myeloma - does it matter?
- Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front...
- Cellular therapies supplement: strategies for improving transplant efficiency in the context of Cellular therapeutics.
- High-dose chemotherapy with autologous stem Cell rescue for relapse after allo-SCT in multiple myeloma.
- In vivo expansion of the megakaryocyte progenitor Cell population in adult CD26-deficient mice.
- Effective mobilization of hematopoietic progenitor Cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
- Mesenchymal stem Cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem Cells during lo...
- Idiopathic hemophagocytic syndrome with a fulminant clinical course.
- Use of radioimmunotherapy in stem Cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetan.
- Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's Lymphoma.
- Crypt loss is a marker of clinical severity of Acute gastrointestinal graft-versus-host disease.
- Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin Lymphoma.
- Does follicularity in large cell Lymphoma predict outcome after autologous stem cell transplantation?
- A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem Cell transplant...
- Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for Lymphoma.
- Late mortality in survivors of autologous hematopoietic-Cell transplantation: report from the Bone Marrow Transplant Survivor Study.
- Efficacy of mycophenolate mofetil in the treatment of Chronic graft-versus-host disease.
- Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients ...
- A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory Acute myelogenous leukemia: impact of cytogenetic characteris...
- Reduced-intensity allogeneic stem Cell transplantation for patients whose prior autologous stem Cell transplantation for hematologic malignancy failed.
- Interleukin-2 after autologous stem-cell transplantation for adult patients with Acute myeloid leukemia in first complete remission.
- Approach to Hodgkin's Lymphoma in the new millennium.
- Is there an association between total-body irradiation and secondary Acute myelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's...
- Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of Acute leukemia and lymphoma.
- Lymphoproliferative Disorders following allogeneic bone marrow transplantation: the Vancouver experience.
- Bone marrow transplantation for adults with Acute leukaemia and 11q23 chromosomal abnormalities.
- High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem Cell transplantation.
- Cytogenetic abnormalities in primary Myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.
- Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors.
- Validation of a high-performance liquid chromatographic assay method for pharmacokinetic evaluation of busulfan.
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Burkitt's Lymphoma
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- HealthPartners
- Community Blue PPO
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Preferred PPO
- Keystone Health Plan East HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Scott & White Health Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- American Top Doctor (Cancer)
- America's Top Doctor (Hem)
- FRCPE
- FACP
- CMS Meaningful Use Stage 1 Certification
Education
-
Chinese University of Hong Kong
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Archana Anantharaman, MD |
|
|
Dr. Therese Bittermann, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew T. Hurford, MD |
|
|
Dr. David W. Essex, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristine M. Ward, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen A. Liebhaber, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alan M. Gewirtz, MD |
|
Dr. Christina Brus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Styler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Topolsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam C. Cuker, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. James K. Mangan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Courtney D. Dinardo, MD |